American International Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-216
| Closed | -$65 | – | 3186 |
|
2021
Q1 | $65 | Buy |
216
+1
| +0.5% | – | ﹤0.01% | 2906 |
|
2020
Q4 | $81 | Sell |
215
-7
| -3% | -$3 | ﹤0.01% | 2757 |
|
2020
Q3 | $68K | Buy |
222
+15
| +7% | +$4.6K | ﹤0.01% | 2737 |
|
2020
Q2 | $78K | Buy |
207
+7
| +4% | +$2.64K | ﹤0.01% | 2680 |
|
2020
Q1 | $46K | Sell |
200
-12
| -6% | -$2.76K | ﹤0.01% | 2712 |
|
2019
Q4 | $112K | Sell |
212
-2
| -0.9% | -$1.06K | ﹤0.01% | 2562 |
|
2019
Q3 | $92K | Sell |
214
-1
| -0.5% | -$430 | ﹤0.01% | 2658 |
|
2019
Q2 | $256K | Sell |
215
-2
| -0.9% | -$2.38K | ﹤0.01% | 2078 |
|
2019
Q1 | $271K | Sell |
217
-7
| -3% | -$8.74K | ﹤0.01% | 2041 |
|
2018
Q4 | $212K | Sell |
224
-2
| -0.9% | -$1.89K | ﹤0.01% | 2154 |
|
2018
Q3 | $325K | Buy |
226
+7
| +3% | +$10.1K | ﹤0.01% | 2131 |
|
2018
Q2 | $353K | Buy |
+219
| New | +$353K | ﹤0.01% | 2041 |
|
2017
Q2 | – | Sell |
-64
| Closed | -$35K | – | 3092 |
|
2017
Q1 | $35K | Buy |
64
+5
| +8% | +$2.73K | ﹤0.01% | 2901 |
|
2016
Q4 | $36K | Hold |
59
| – | – | ﹤0.01% | 2913 |
|
2016
Q3 | $42.2K | Hold |
59
| – | – | ﹤0.01% | 2932 |
|
2016
Q2 | $42.9K | Buy |
+59
| New | +$42.9K | ﹤0.01% | 2984 |
|